VBI Vaccines Reports Full Year 2023 Financial ResultsBusiness Wire • 20 days agoVBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced...